These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
523 related articles for article (PubMed ID: 3582068)
1. DNA ploidy and survival in breast cancer patients. Cornelisse CJ; van de Velde CJ; Caspers RJ; Moolenaar AJ; Hermans J Cytometry; 1987 Mar; 8(2):225-34. PubMed ID: 3582068 [TBL] [Abstract][Full Text] [Related]
2. Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients. Hedley DW; Rugg CA; Ng AB; Taylor IW Cancer Res; 1984 Nov; 44(11):5395-8. PubMed ID: 6488193 [TBL] [Abstract][Full Text] [Related]
3. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer]. Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702 [TBL] [Abstract][Full Text] [Related]
4. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors. Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of DNA ploidy status in patients with rectal cancer. Berczi C; Bocsi J; Bartha I; Math J; Balazs G Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986 [TBL] [Abstract][Full Text] [Related]
6. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. Clark GM; Dressler LG; Owens MA; Pounds G; Oldaker T; McGuire WL N Engl J Med; 1989 Mar; 320(10):627-33. PubMed ID: 2918874 [TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328 [TBL] [Abstract][Full Text] [Related]
8. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
9. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters. Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041 [TBL] [Abstract][Full Text] [Related]
10. Prognostic value of DNA ploidy in breast cancer stage I-II. Cufer T; Lamovec J; Bracko M; Lindtner J; Us-Krasovec M Neoplasma; 1997; 44(2):127-32. PubMed ID: 9201293 [TBL] [Abstract][Full Text] [Related]
11. [DNA analysis by flow cytometry in breast carcinoma]. Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806 [TBL] [Abstract][Full Text] [Related]
12. Image and flow cytometric analysis of DNA content in breast cancer. Relation to estrogen receptor content and lymph node involvement. Cornelisse CJ; de Koning HR; Moolenaar AJ; van de Velde CJ; Ploem JS Anal Quant Cytol; 1984 Mar; 6(1):9-18. PubMed ID: 6732072 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA ploidy in primary, metastatic and recurrent breast cancers. Tsutsui S; Ohno S; Murakami S; Kataoka A; Kinoshita J; Hachitanda Y Oncol Rep; 2002; 9(4):793-9. PubMed ID: 12066211 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between DNA ploidy and survival in breast cancer]. Utada Y; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():431-5. PubMed ID: 9589048 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of DNA image cytometry in Libyan breast cancer. Ermiah E; Abdalla F; Buhmeida A; Alshrad M; Salem N; Pyrhönen S; Collan Y Oncology; 2012; 83(3):165-76. PubMed ID: 22906963 [TBL] [Abstract][Full Text] [Related]
17. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis. Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729 [TBL] [Abstract][Full Text] [Related]
19. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients]. Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437 [TBL] [Abstract][Full Text] [Related]
20. [Flow cytometry detected S-phase fraction and ploidy as prognostic parameters in primary, node-negative breast cancer]. Winter K; Eidtmann H; Jonat W Geburtshilfe Frauenheilkd; 1994 May; 54(5):291-4. PubMed ID: 8050690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]